Araceli Biosciences Integrated Endeavor Into Nebula Lab

The high-content imaging instrument is now part of Ginkgo Bioworks' Boston-based autonomous facility.

Updated on Oct. 8, 2026 in Biotech

Bold vector editorial illustration showing an automated biological imaging hardware unit in a clinical setting, representing high-throughput laboratory research. — Araceli Biosciences has integrated its high-content imaging system into the Ginkgo Bioworks Nebula facility in Boston to generate datasets for AI-driven drug discovery. AI Illustration. Upload story photo >

Live Poll

Do you believe autonomous lab technology will effectively improve the speed of new drug discovery?

Araceli Biosciences has integrated its Endeavor high-content imaging system into Ginkgo Bioworks' Nebula autonomous laboratory. The integration aims to generate large, curated datasets necessary for training and validating drug discovery AI models.

Why it matters

The integration leverages advanced imaging to accelerate drug discovery by providing the high-quality data required to power artificial intelligence models. This setup allows for continuous automated analysis within a high-throughput lab environment.

The Endeavor system processes 1,536-well plates in under four minutes while utilizing ClaireRT software for real-time analysis. The unit occupies one-third of the space required by a traditional lab bench and operates alongside over 100 Reconfigurable Automation Carts.

The players

Araceli Biosciences

Headquartered in Portland, Oregon, the company develops high-content imaging and analysis solutions for biological research.

Ginkgo Bioworks

Based in Boston, this biotechnology firm operates a massive platform for cell programming and automated lab services.

The details

Integrated into Ginkgo Bioworks' continuous-operation Nebula lab in Boston, the Endeavor system uses ClaireRT software to analyze samples during image capture. This setup allows the system to trigger automatic alerts or halt imaging processes based on predefined criteria, streamlining the experimental workflow.

October 8, 2026: Araceli Biosciences and Ginkgo Bioworks announced the integration of the Endeavor imaging instrument.

The Tech Race

This integration represents a broader industry shift toward fully autonomous, continuous-operation laboratories that replace manual research workflows with high-speed robotics. By incorporating specialized high-content imaging, companies are moving toward a data-first model to train proprietary AI.

For researchers and biotech professionals, this integration signals a move toward higher throughput and automated quality control in drug development workflows. Users of such systems can expect faster processing of large-scale chemical or biological screens with reduced human oversight.

The takeaway

Autonomous laboratory platforms are increasingly dependent on real-time imaging analysis to maintain efficiency and accuracy in high-throughput research. This integration highlights the importance of hardware-software synergy in accelerating the development of data-hungry AI models.